Showing results (191-200 of 269) with videos related to
Sort By:
Pageof 27
AIDS and Behavior|June 6, 2022
Prevalence and Risks of Depression and Substance Use Among Adults Living with HIV in the Asia-Pacific RegionJeremy L Ross, Awachana Jiamsakul, Anchalee Avihingsanon, et al.AIDS (London, England)|September 11, 2023
Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiationSivaporn Gatechompol, Stephen J Kerr, Sandra W Cardoso, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2019
Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority TrialCissy Kityo, Debbie Hagins, Ellen Koenig, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 30, 2025
Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)-Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV CoinfectionJennifer Audsley, Anchalee Avihingsanon, Xin Li, et al.Antimicrobial Agents and Chemotherapy|September 2, 2020
Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive PatientsMartina L Reichmuth, Rico Hömke, Kathrin Zürcher, et al.Hepatology (Baltimore, Md.)|January 13, 2015
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countriesDorothée Obach, Yazdan Yazdanpanah, Gamal Esmat, et al.AIDS (London, England)|February 2, 2023
Factors associated with reduced function and quality of life among adult people with HIV with depression and substance use in the Asia-Pacific regionReena Rajasuriar, Meng Li Chong, Jeremy L Ross, et al.Pharmacogenetics and Genomics|February 17, 2025
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosisNia Covington, Anne F Luetkemeyer, Marjorie Z Imperial, et al.HIV Research & Clinical Practice|July 16, 2019
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trialsYeon-Sook Kim, Shinichi Oka, Ploenchan Chetchotisakd, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virusGail V Matthews, Eric C Seaberg, Anchalee Avihingsanon, et al.Pageof 27